Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides

International Dairy Journal

Volumn 22, Issue 2, 2012, Pages 123-140

  Venema, Koen ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN MILK OLIGOSACCHARIDES; MICROBIOTAS; MOLECULAR TOOLS; PREBIOTICS;

FERMENTATION; ISOTOPES; METABOLITES; OLIGOSACCHARIDES; SACCHARIFICATION;

SUBSTRATES;

EID: 83055184112     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2011.10.011     Document Type: Review

References (197)

1. Adam A.C., Rubio-Texeira M., Polaina J. Lactose: the milk sugar from a biotechnological perspective. Critical Reviews in Food Science and Nutrition 2004, 44:553-557.
2. Ahmad M.S., Krishnan S., Ramakrishna B.S., Mathan M., Pulimood A.B., Murthy S.N. Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut 2000, 46:493-499.
3. Al-Lahham, S. H. (2010). Propionate: a candidate metabolite to link human adipose tissue inflammation and microbiota PhD thesis. Groningen, The Netherlands: University of Groningen, University Medical Center Groningen. ISBN: 978-90-367-4495-9.
4. Al-Lahham S.H., Roelofsen H., Priebe M., Weening D., Dijkstra M., Hoek A., et al. Regulation of adipokine production in human adipose tissue by propionic acid. European Journal of Clinical Investigation 2010, 40:401-407.
5. Al-Lahham S., Roelofsen H., Rezaee F., Weening D., Hoek A., Vonk R., et al. Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. European Journal of Clinical Investigation 2011, Epub ahead of print. 10.1111/j.1365-2362.2011.02590.x.
6. Arola H., Tamm A. Metabolism of lactose in the human body. Scandanavian Journal of Gastroenterology 1994, 202:21-25.
7. Arslanoglu S., Moro G.E., Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. Journal of Nutrition 2007, 137:2420-2424.
8. Arslanoglu S., Moro G.E., Schmitt J., Tandoi L., Rizzardi S., Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. Journal of Nutrition 2008, 138:1091-1095.
9. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
10. Ashida H., Miyake A., Kiyohara M., Wada J., Yoshida E., Kumagai H., et al. Two distinct alpha-l-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 2009, 19:1010-1017.
11. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
12. Bakker-Zierikzee A.M., Alles M.S., Knol J., Kok F.J., Tolboom J.J., Bindels J.G. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. British Journal of Nutrition 2005, 94:783-790.
13. Ballongue J., Schumann C., Quignon P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scandanavian Journal of Gastroenterology 1997, 222:41-44.
14. Bartlett J.G. Clinical practice. Antibiotic-associated diarrhea. New England Journal of Medicine 2002, 346:334-339.
15. Ben X.M., Li J., Feng Z.T., Shi S.Y., Lu Y.D., Chen R., et al. Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World Journal of Gastroenterology 2008, 14:6564-6568.
16. Ben-Amor K., Heilig H., Smidt H., Vaughan E.E., Abee T., de Vos W.M. Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Applied and Environmental Microbiology 2005, 71:4679-4689.
17. Bergman E.N. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiological Reviews 1990, 70:567-590.
18. Birkett A., Muir J., Phillips J., Jones G., O'Dea K. Resistant starch lowers fecal concentrations of ammonia and phenols in humans. American Journal of Clinical Nutrition 1996, 63:766-772.
19. Bloemen J.G., Venema K., van de Poll M.C., Olde Damink S.W., Buurman W.A., Dejong C.H. Short chain fatty acids exchange across the gut and liver in humans measured at surgery. Clinical Nutrition 2009, 28:657-661.
20. Bode L. Human milk oligosaccharides: prebiotics and beyond. Nutrition Reviews 2009, 67(Suppl. 2):S183-S191.
21. Bouhnik Y., Raskine L., Simoneau G., Vicaut E., Neut C., Flourie B., et al. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. American Journal of Clinical Nutrition 2004, 80:1658-1664.
22. Campbell J.M., Fahey G.C., Wolf B.W. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. Journal of Nutrition 1997, 127:130-136.
23. Cappello G., Marzio L. Rifaximin in patients with lactose intolerance. Digestive and Liver Disease 2005, 37:316-319.
24. Chapman M.A., Grahn M.F., Boyle M.A., Hutton M., Rogers J., Williams N.S. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994, 35:73-76.
25. Chassany O., Michaux A., Bergmann J.F. Drug-induced diarrhoea. Drug Safety 2000, 22:53-72.
26. Chen C., Li L., Wu Z., Chen H., Fu S. Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis. Journal of Infection 2007, 54:98-102.
27. Cherbut C., Michel C., Lecannu G. The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. Journal of Nutrition 2003, 133:21-27.
28. Clausen M.R., Jorgensen J., Mortensen P.B. Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate. Digestive Diseases and Sciences 1998, 43:2696-2707.
29. Collins M.D., Gibson G.R. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. American Journal of Clinical Nutrition 1999, 69:1052S-1057S.
30. Coppa G.V., Bruni S., Morelli L., Soldi S., Gabrielli O. The first prebiotics in humans: human milk oligosaccharides. Journal of Clinical Gastroenterology 2004, 38:S80-S83.
31. Coppa G.V., Zampini L., Galeazzi T., Gabrielli O. Prebiotics in human milk: a review. Digestive and Liver Disease 2006, 38(Suppl. 2):S291-S294.
32. Costalos C., Kapiki A., Apostolou M., Papathoma E. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Human Development 2008, 84:45-49.
33. Coulier L., Timmermans J., Bas R., Van Den Dool R., Haaksman I., Klarenbeek B., et al. In-depth characterization of prebiotic galacto-oligosaccharides by a combination of analytical techniques. Journal of Agricultural and Food Chemistry 2009, 57:8488-8495.
34. Cummings J.H. Production and metabolism of short-chain fatty acids in humans. Short-chain fatty acids: Metabolism and clinical importance. Report of the tenth Ross conference on medical research 1991, 11-17. Ross Laboratories, Columbus, OH, USA. A.F. Roche (Ed.).
35. Cummings J.H. Short chain fatty acids. Human colonic bacteria: Role in nutrition, physiology, and pathology 1995, 101-130. CRC Press, Boca Raton, FL, USA. G.R. Gibson, G.T. Macfarlane (Eds.).
36. Cummings J.H., Macfarlane G.T. The control and consequences of bacterial fermentation in the human colon. Journal of Applied Bacteriology 1991, 70:443-459.
37. Cummings J.H., Macfarlane G.T. Role of intestinal bacteria in nutrient metabolism. Journal of Parenteral and Enteral Nutrition 1997, 21:357-365.
38. Cummings J.H., Pomare E.W., Branch W.J., Naylor C.P., Macfarlane G.T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987, 28:1221-1227.
39. Davis L.M., Martinez I., Walter J., Hutkins R. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. International Journal of Food Microbiology 2010, 144:285-292.
40. Depeint F., Tzortzis G., Vulevic J., I'Anson K., Gibson G.R. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. American Journal of Clinical Nutrition 2008, 87:785-791.
41. Egert M., de Graaf A.A., Maathuis A., de Waard P., Plugge C.M., Smidt H., et al. Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing. FEMS Microbiology Ecology 2007, 60:126-135.
42. Egert M., de Graaf A.A., Smidt H., de Vos W.M., Venema K. Beyond diversity: functional microbiomics of the human colon. Trends in Microbiology 2006, 14:86-91.
43. Eiwegger T., Stahl B., Haidl P., Schmitt J., Boehm G., Dehlink E., et al. Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatric Allergy and Immunology 2010, 21:1179-1188.
44. Eiwegger T., Stahl B., Schmitt J., Boehm G., Gerstmayr M., Pichler J., et al. Human milk-derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatric Research 2004, 56:536-540.
45. Fanaro S., Boehm G., Garssen J., Knol J., Mosca F., Stahl B., et al. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review. Acta Paediatrica 2005, 94:22-26.
46. Fanaro S., Marten B., Bagna R., Vigi V., Fabris C., Pena-Quintana L., et al. Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. Journal of Pediatric Gastroenterology and Nutrition 2009, 48:82-88.
47. Finney M., Smullen J., Foster H.A., Brokx S., Storey D.M. Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology. European Journal of Nutrition 2007, 46:307-314.
48. Florent C., Flourie B., Leblond A., Rautureau M., Bernier J.J., Rambaud J.C. Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). Journal of Clinical Investigation 1985, 75:608-613.
49. Gamet L., Daviaud D., Denis-Pouxviel C., Remesy C., Murat J.C. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29. International Journal of Cancer 1992, 52:286-289.
50. Gänzle M.G., Haase G., Jelen P. Lactose: crystallization, hydrolysis and value-added derivatives. International Dairy Journal 2008, 18:685-694.
51. German J.B., Freeman S.L., Lebrilla C.B., Mills D.A. Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. Nestle Nutrition Workshop Series. Pediatric Programme 2008, 62:205-218. discussion 218-222.
52. Gibson P.R., Moeller I., Kagelari O., Folino M., Young G.P. Contrasting effects of butyrate on the expression of phenotypic markers of differentiation in neoplastic and non-neoplastic colonic epithelial cells in vitro. Journal of Gastroenterology and Hepatology 1992, 7:165-172.
53. Gibson G.R., Probert H.M., Loo J.V., Rastall R.A., Roberfroid M.B. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutrition Research Reviews 2004, 17:259-275.
54. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition 1995, 125:1401-1412.
55. Gibson P., Rosella O. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut 1995, 37:536-543.
56. Goulas T., Goulas A., Tzortzis G., Gibson G.R. Comparative analysis of four beta-galactosidases from Bifidobacterium bifidum NCIMB41171: purification and biochemical characterisation. Applied Microbiology and Biotechnology 2009, 82:1079-1088.
57. de Graaf A.A., Maathuis A., de Waard P., Deutz N.E., Dijkema C., de Vos W.M., et al. Profiling human gut bacterial metabolism and its kinetics using [U-13C]glucose and NMR. NMR in Biomedicine 2010, 23:2-12.
58. de Graaf A.A., Venema K. Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. Advances in Microbial Physiology 2008, 53:73-168.
59. Grabitske H.A., Slavin J.L. Gastrointestinal effects of low-digestible carbohydrates. Critical Reviews in Food Science and Nutrition 2009, 49:327-360.
60. Haarman M., Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Applied and Environmental Microbiology 2005, 71:2318-2324.
61. Haarman M., Knol J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Applied and Environmental Microbiology 2006, 72:2359-2365.
62. Hague A., Singh B., Paraskeva C. Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology 1997, 112:1036-1040.
63. Hamer H.M., Jonkers D.M., Bast A., Vanhoutvin S.A., Fischer M.A., Kodde A., et al. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clinical Nutrition 2009, 28:88-93.
64. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. Review article: the role of butyrate on colonic function. Alimentary Pharmacology and Therapeutics 2008, 27:104-119.
65. Hammer H.F., Petritsch W., Pristautz H., Krejs G.J. Evaluation of the pathogenesis of flatulence and abdominal cramps in patients with lactose malabsorption. Wiener Klinische Wochenschrift 1996, 108:175-179.
66. Hammer H.F., Santa Ana C.A., Schiller L.R., Fordtran J.S. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. Journal of Clinical Investigation 1989, 84:1056-1062.
67. Harig J.M., Soergel K.H., Komorowski R.A., Wood C.M. Treatment of diversion colitis with short-chain-fatty acid irrigation. New England Journal of Medicine 1989, 320:23-28.
68. Havenaar R., Van Dokkum W. Lactulose. A review on effects, clinical results, and safety aspects in relation to its influence on the colonic environment. Handbook of dietary fibre 2001, 179-193. Marcel Dekker, New York, NY, USA. S. Sungsoo Cho, M.L. Dreher (Eds.).
69. He T., Priebe M.G., Harmsen H.J., Stellaard F., Sun X., Welling G.W., et al. Colonic fermentation may play a role in lactose intolerance in humans. Journal of Nutrition 2006, 136:58-63.
70. He T., Priebe M.G., Vonk R.J., Welling G.W. Identification of bacteria with beta-galactosidase activity in faeces from lactase non-persistent subjects. FEMS Microbiology Ecology 2005, 54:463-469.
71. He T., Priebe M.G., Welling G.W., Vonk R.J. Effect of lactose on oro-cecal transit in lactose digesters and maldigesters. European Journal of Clinical Investigation 2006, 36:737-742.
72. He T., Venema K., Priebe M.G., Welling G.W., Brummer R.J., Vonk R.J. The role of colonic metabolism in lactose intolerance. European Journal of Clinical Investigation 2008, 38:541-547.
73. Hertzler S.R., Savaiano D.A. Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. American Journal of Clinical Nutrition 1996, 64:232-236.
74. Hickey, R.M. Human milk oligosaccharides and prevention of pathogen adhesion. International Dairy Journal, in press.
75. Hill M.J. The metabolic activity of gut bacteria. Role of gut bacteria in human toxicology and pharmacology 1995, 19-25. Taylor & Francis Ltd, London, UK. M.J. Hill (Ed.).
76. Hill M.J., Ellwood D.C., Watson J.H.P. Sulfate-reducing bacteria (SRB). Role of gut bacteria in human toxicology and pharmacology 1995, 187-193. Taylor & Francis Ltd, London, UK. M.J. Hill (Ed.).
77. van Hoffen E., Ruiter B., Faber J., M'Rabet L., Knol E.F., Stahl B., et al. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 2009, 64:484-487.
78. Hogenauer C., Hammer H.F., Krejs G.J., Reisinger E.C. Mechanisms and management of antibiotic-associated diarrhea. Clinical Infectious Diseases 1998, 27:702-710.
79. Hugenholtz P., Goebel B.M., Pace N.R. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. Journal of Bacteriology 1998, 180:4765-4774.
80. Ito M., Deguchi Y., Matsumoto K., Kimura M., Onodera N., Yajima T. Influence of galactooligosaccharides on the human fecal microflora. Journal of Nutritional Science and Vitaminology (Tokyo) 1993, 39:635-640.
81. Jouet P., Sabate J.M., Cuillerier E., Coffin B., Lemann M., Jian R., et al. Low-dose lactulose produces a tonic contraction in the human colon. Neurogastroenterology and Motility 2006, 18:45-52.
82. Jouet P., Sabate J.M., Flourie B., Cuillerier E., Gambini D., Lemann M., et al. Effects of therapeutic doses of lactulose vs. polyethylene glycol on isotopic colonic transit. Alimentary Pharmacology and Therapeutics 2008, 27:988-993.
83. Kelleher J.K. Probing metabolic pathways with isotopic tracers: insights from mammalian metabolic physiology. Metabolic Engineering 2004, 6:1-5.
84. Kien C.L., Kepner J., Grotjohn K., Ault K., McClead R.E. Stable isotope model for estimating colonic acetate production in premature infants. Gastroenterology 1992, 102:1458-1466.
85. Kien C.L., Murray R.D., Ailabouni A., Powers P., Kepner J., Powers L., et al. Stable isotope model for assessing production of short chain fatty acids from colon-derived sugar: application in pigs. Journal of Nutrition 1996, 126:3069-3076.
86. Kiyohara M., Tachizawa A., Nishimoto M., Kitaoka M., Ashida H., Yamamoto K. Prebiotic effect of lacto-N-biose I on bifidobacterial growth. Bioscience, Biotechnology and Biochemistry 2009, 73:1175-1179.
87. Knol J., Boehm G., Lidestri M., Negretti F., Jelinek J., Agosti M., et al. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatrica 2005, 94:31-33.
88. Knol J., Scholtens P., Kafka C., Steenbakkers J., Gro S., Helm K., et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. Journal of Pediatric Gastroenterology and Nutrition 2005, 40:36-42.
89. Kobata A. Structures and application of oligosaccharides in human milk. Proceedings of the Japan Acadamy. Series B, Physical and Biological Sciences 2010, 86:731-747.
90. Korula J. Review: lactulose or lactitol may improve hepatic encephalopathy but may be less effective than antibiotics. ACP Journal Club 2004, 141:59.
91. Kovatcheva-Datchary, P. (2010). Analyzing the functionality of the human intestinal microbiota by stable isotope probing PhD thesis. The Netherlands: University of Wageningen, Wageningen. ISBN: 978-90-8585-685-6.
92. Kovatcheva-Datchary P., Egert M., Maathuis A., Rajilic-Stojanovic M., de Graaf A.A., Smidt H., et al. Linking phylogenetic identities of bacteria to starch fermentation in an in vitro model of the large intestine by RNA-based stable isotope probing. Environmental Microbiology 2009, 11:914-926.
93. Kruh J., Defer N., Tichonicky L. Molecular and cellular effects of sodium butyrate. Short-chain fatty acids: Metabolism and clinical importance. Report of the tenth Ross conference on medical research 1991, 45-50. Ross Laboratories, Columbus, OH, USA. A.F. Roche (Ed.).
94. Kunz C., Rudloff S. Structural and functional aspects of oligosaccharides in human milk. Zeitschrift fur Ernahrungswissenschaft 1996, 35:22-31.
95. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annual Review of Nutrition 2000, 20:699-722.
96. Lee J.H., O'Sullivan D.J. Genomic insights into bifidobacteria. Microbiology and Molecular Biology Reviews 2010, 74:378-416.
97. Levine J., Ellis C.J., Furne J.K., Springfield J., Levitt M.D. Fecal hydrogen sulfide production in ulcerative colitis. American Journal of Gastroenterology 1998, 93:83-87.
98. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:11070-11075.
99. LoCascio R.G., Desai P., Sela D.A., Weimer B., Mills D.A. Comparative genomic hybridization of Bifidobacterium longum strains reveals broad conservation of milk utilization genes in subsp. infantis. Applied and Environmental Microbiology 2010, 76:7373-7381.
100. LoCascio R.G., Ninonuevo M.R., Freeman S.L., Sela D.A., Grimm R., Lebrilla C.B., et al. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. Journal of Agricultural and Food Chemistry 2007, 55:8914-8919.
101. Maathuis A., Hoffman A., Evans A., Sanders L., Venema K. The effect of the undigested fraction of maize products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human proximal large intestine. Journal of the American College of Nutrition 2009, 28:657-666.
102. Macfarlane G.T., Cummings J.H. The colonic flora, fermentation and large bowel digestive function. The large intestine: Physiology, pathophysiology, and disease 1991, 51-92. Raven Press, New York, NY, USA. S.F. Phillips, J.H. Pemberton, R.G. Shorter (Eds.).
103. Macfarlane G.T., Gibson G.R., Cummings J.H. In vivo and in vitro studies on formation of phenols and phenolic acids by human colonic bacteria. Growth Development Nutrition 1992, A565.
104. Macfarlane G.T., Gibson G.R., Cummings J.H. Comparison of fermentation reactions in different regions of the human colon. Journal of Applied Bacteriology 1992, 72:57-64.
105. Macfarlane S., Macfarlane G.T. Proteolysis and amino acid fermentation. Human colonic bacteria: Role in nutrition, physiology, and pathology 1995, 75-100. CRC Press, Boca Raton, FL, USA. G.R. Gibson, G.T. MacFarlane (Eds.).
106. McIntyre A., Gibson P.R., Young G.P. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 1993, 34:386-391.
107. Magne F., Hachelaf W., Suau A., Boudraa G., Bouziane-Nedjadi K., Rigottier-Gois L., et al. Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding. Journal of Pediatric Gastroenterology and Nutrition 2008, 46:580-588.
108. Marcobal A., Barboza M., Froehlich J.W., Block D.E., German J.B., Lebrilla C.B., et al. Consumption of human milk oligosaccharides by gut-related microbes. Journal of Agricultural and Food Chemistry 2010, 58:5334-5340.
109. Mariadason J.M., Corner G.A., Augenlicht L.H. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Research 2000, 60:4561-4572.
110. Mariadason J.M., Rickard K.L., Barkla D.H., Augenlicht L.H., Gibson P.R. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. Journal of Cell Physiology 2000, 183:347-354.
111. Marteau P., Flourie B., Pochart P., Chastang C., Desjeux J.F., Rambaud J.C. Effect of the microbial lactase (EC 3.2.1.23) activity in yoghurt on the intestinal absorption of lactose: an in vivo study in lactase-deficient humans. British Journal of Nutrition 1990, 64:71-79.
112. Marteau P., Seksik P., Jian R. Probiotics and intestinal health effects: a clinical perspective. British Journal of Nutrition 2002, 88(Suppl. 1):S51-S57.
113. Martin M.J., Martin-Sosa S., Hueso P. Binding of milk oligosaccharides by several enterotoxigenic Escherichia coli strains isolated from calves. Glycoconjugate Journal 2002, 19:5-11.
114. Meesters R.J., Wolfe R.R., Deutz N.E. Application of liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the analysis of stable isotope enrichments of phenylalanine and tyrosine. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2009, 877:43-49.
115. Miller G.D., Jarvis J.K., McBean L.D. Handbook of dairy foods and nutrition 2000, CRC Press, Boca Raton, FL, USA. 2nd ed.
116. Miller T.L., Wolin M.J. Fermentations by saccharolytic intestinal bacteria. American Journal of Clinical Nutrition 1979, 32:164-172.
117. Minekus M., Smeets-Peeters M., Bernalier A., Marol-Bonnin S., Havenaar R., Marteau P., et al. A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Applied Microbiology and Biotechnology 1999, 53:108-114.
118. Miwa M., Horimoto T., Kiyohara M., Katayama T., Kitaoka M., Ashida H., et al. Cooperation of {beta}-galactosidase and {beta}-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure. Glycobiology 2010, 20:1402-1409.
119. Moro G., Minoli I., Mosca M., Fanaro S., Jelinek J., Stahl B., Boehm G. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. Journal of Pediatric Gastroenterology and Nutrition 2002, 34:291-295.
120. Moro G.E., Stahl B., Fanaro S., Jelinek J., Boehm G., Coppa G.V. Dietary prebiotic oligosaccharides are detectable in the faeces of formula-fed infants. Acta Paediatrica 2005, 94:27-30.
121. Mustapha A., Hertzler S.R., Savaiano D.A. Lactose: nutritional significance. Lactose, water, salts and vitamins 1997, Vol. 3. Chapman and Hall, London, UK. P.F. Fox (Ed.).
122. Napoli J.E., Brand-Miller J.C., Conway P. Bifidogenic effects of feeding infant formula containing galacto-oligosaccharides in healthy formula-fed infants. Asia Pacific Journal of Clinical Nutrition 2003, 12:S60.
123. Nelson K.E., Weinstock G.M., Highlander S.K., Worley K.C., Creasy H.H., Wortman J.R., et al. A catalog of reference genomes from the human microbiome. Science 2010, 328:994-999.
124. Newburg D.S. Oligosaccharides and glycoconjugates in human milk: their role in host defense. Journal of Mammary Gland Biology and Neoplasia 1996, 1:271-283.
125. Newburg D.S., Neubauer S.H. Carbohydrates in Milks: analysis, quantities and significance. Handbook of milk composition 1995, 273-349. Academic Press, San Diego, CA, USA. R.G. Jensen (Ed.).
126. Okamoto T., Sasaki M., Tsujikawa T., Fujiyama Y., Bamba T., Kusunoki M. Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats. Journal of Gastroenterology 2000, 35:341-346.
127. Oku T., Nakamura S. Digestion, absorption, fermentation, and metabolism of functional sugar substitutes and their available energy. Pure and Applied Chemistry 2002, 74:1253-1261.
128. Oku T., Nakamura S. Comparison of digestibility and breath hydrogen gas excretion of fructo-oligosaccharide, galactosyl-sucrose, and isomalto-oligosaccharide in healthy human subjects. European Journal of Clinical Investigation 2003, 57:1150-1156.
129. Ouwehand A.C., Tiihonen K., Saarinen M., Putaala H., Rautonen N. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. British Journal of Nutrition 2009, 101:367-375.
130. Palmer C., Bik E.M., Eisen M.B., Eckburg P.B., Sana T.R., Wolber P.K., et al. Rapid quantitative profiling of complex microbial populations. Nucleic Acids Research 2006, 34:e5.
131. Peer D. Induction of therapeutic gene silencing in leukocyte-implicated diseases by targeted and stabilized nanoparticles: a mini-review. Journal of Controlled Release 2010, 148:63-68.
132. Phongsamran P.V., Kim J.W., Cupo Abbott J., Rosenblatt A. Pharmacotherapy for hepatic encephalopathy. Drugs 2010, 70:1131-1148.
133. Piirainen L., Kekkonen R.A., Kajander K., Ahlroos T., Tynkkynen S., Nevala R., et al. In school-aged children a combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own. Annals of Nutrition and Metabolism 2008, 52:204-208.
134. Pontes F.A., Silva A.T., Cruz A.C. Colonic transit times and the effect of lactulose or lactitol in hospitalized patients. European Journal of Gastroenterology and Hepatology 1995, 7:441-446.
135. Pouteau E., Nguyen P., Ballevre O., Krempf M. Production rates and metabolism of short-chain fatty acids in the colon and whole body using stable isotopes. Proceedings of the Nutrition Society 2003, 62:87-93.
136. Pouteau E., Vahedi K., Messing B., Flourie B., Nguyen P., Darmaun D., et al. Production rate of acetate during colonic fermentation of lactulose: a stable-isotope study in humans. American Journal of Clinical Nutrition 1998, 68:1276-1283.
137. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
138. Rajilic-Stojanovic M., Heilig H.G., Molenaar D., Kajander K., Surakka A., Smidt H., et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environmental Microbiology 2009, 11:1736-1751.
139. Rechkemmer G., Ronnau K., von Engelhardt W. Fermentation of polysaccharides and absorption of short chain fatty acids in the mammalian hindgut. Comparative Biochemistry and Physiology Part A: Physiology 1988, 90:563-568.
140. Reilly K.J., Rombeau J.L. Metabolism and potential clinical applications of short-chain fatty acids. Clinical Nutrition 1993, 12:S97-S105.
141. Relman D.A., Falkow S. The meaning and impact of the human genome sequence for microbiology. Trends in Microbiology 2001, 9:206-208.
142. Riggio O., Varriale M., Testore G.P., Di Rosa R., Di Rosa E., Merli M., et al. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients. Journal of Clinical Gastroenterology 1990, 12:433-436.
143. Rigottier-Gois L., Bourhis A.G., Gramet G., Rochet V., Dore J. Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiology Ecology 2003, 43:237-245.
144. Riordan S.M., Williams R. Gut flora and hepatic encephalopathy in patients with cirrhosis. New England Journal of Medicine 2010, 362:1140-1142.
145. Roberfroid M., Gibson G.R., Delzenne N. The biochemistry of oligofructose, a nondigestible fiber: an approach to calculate its caloric value. Nutrition Reviews 1993, 51:137-146.
146. Roediger W.E. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 1982, 83:424-429.
147. Rose D.J., Venema K., Keshavarzian A., Hamaker B.R. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease. British Journal of Nutrition 2010, 103:1514-1524.
148. Rowe W.A., Bayless T.M. Colonic short-chain fatty acids: fuel from the lumen?. Gastroenterology 1992, 103:336-338.
149. Rowland I.R. Toxicology of the colon: role of the intestinal microflora. Human colonic bacteria: Role in nutrition, physiology, and pathology 1995, 155-174. CRC Press, Boca Raton, FL, USA. G.R. Gibson, G.T. Macfarlane (Eds.).
150. Ruppin H., Bar-Meir S., Soergel K.H., Wood C.M., Schmitt M.G. Absorption of short-chain fatty acids by the colon. Gastroenterology 1980, 78:1500-1507.
151. Saavedra J.M., Perman J.A. Current concepts in lactose malabsorption and intolerance. Annual Review of Nutrition 1989, 9:475-502.
152. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994, 35:S35-S38.
153. Scheppach W., Christl S.U., Bartram H.P., Richter F., Kasper H. Effects of short-chain fatty acids on the inflamed colonic mucosa. Scandanavian Journal of Gastroenterology 1997, 222:53-57.
154. Scheppach W., Sommer H., Kirchner T., Paganelli G.M., Bartram P., Christl S., et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992, 103:51-56.
155. Scholtens P.A., Alles M.S., Bindels J.G., van der Linde E.G., Tolboom J.J., Knol J. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. Journal of Pediatric Gastroenterology and Nutrition 2006, 42:553-559.
156. Schultz M. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflammatory Bowel Disease 2008, 14:1012-1018.
157. Sela D.A., Chapman J., Adeuya A., Kim J.H., Chen F., Whitehead T.R., et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:18964-18969.
158. Sela D.A., Mills D.A. Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends in Microbiology 2010, 18:298-307.
159. Shaukat A., Levitt M.D., Taylor B.C., MacDonald R., Shamliyan T.A., Kane R.L., et al. Systematic review: effective management strategies for lactose intolerance. Annals of Internal Medicine 2010, 152:797-803.
160. Singh B., Halestrap A.P., Paraskeva C. Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis 1997, 18:1265-1270.
161. Suarez F., Levitt M. Lactose malabsorption and diarrhea. Nutrition 1997, 13:53-54.
162. Suau A., Bonnet R., Sutren M., Godon J.J., Gibson G.R., Collins M.D., et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Applied and Environmental Microbiology 1999, 65:4799-4807.
163. Suzuki R., Wada J., Katayama T., Fushinobu S., Wakagi T., Shoun H., et al. Structural and thermodynamic analyses of solute-binding protein from Bifidobacterium longum specific for core 1 disaccharide and lacto-N-biose I. Journal of Biological Chemistry 2008, 283:13165-13173.
164. Szilagyi A. Review article: lactose - a potential prebiotic. Alimentary Pharmacology and Therapeutics 2002, 16:1591-1602.
165. Szilagyi A. Redefining lactose as a conditional prebiotic. Canadian Journal of Gastroenterology 2004, 18:163-167.
166. Ten Bruggencate S.J., Bovee-Oudenhoven I.M., Lettink-Wissink M.L., Katan M.B., Van der Meer R. Dietary fructooligosaccharides affect intestinal barrier function in healthy men. Journal of Nutrition 2006, 136:70-74.
167. Ten Bruggencate S.J., Bovee-Oudenhoven I.M., Lettink-Wissink M.L., Van der Meer R. Dietary fructooligosaccharides increase intestinal permeability in rats. Journal of Nutrition 2005, 135:837-842.
168. Terada A., Hara H., Kataoka M., Mitsuoka T. Effects of lactulose on the composition and metabolic activity of human fecal microflora. Microbial Ecology in Health and Disease 1992, 5:43-50.
169. Terada A., Hara H., Li S.T., Ikegame K., Sasaki M., Mitsuoka T. Lecithinase-positive clostridia isolated from human feces on consumption of lactulose and lactosucrose. Japanese Journal of Food Microbiology 1994, 11:119-123.
170. Thurl S., Henker J., Siegel M., Tovar K., Sawatzki G. Detection of four human milk groups with respect to Lewis blood group dependent oligosaccharides. Glycoconjugate Journal 1997, 14:795-799.
171. Thurl S., Munzert M., Henker J., Boehm G., Muller-Werner B., Jelinek J., et al. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. British Journal of Nutrition 2010, 1-11.
172. Urashima T., Kitaoka M., Asakuma S., Messer M. Milk oligosaccharides. Lactose, water, salts and minor constituents 2009, Vol. 3:295-349. Springer-Verlag, New York, NY, USA. P.L.H. McSweeney, P.F. Fox (Eds.).
173. Uribarri J., Oh M.S., Carroll H.J. d-Lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore) 1998, 77:73-82.
174. Uribe-Esquivel M., Moran S., Poo J.L., Munoz R.M. In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters. Scandanavian Journal of Gastroenterology 1997, 222:49-52.
175. Vanhoutvin S.A., Troost F.J., Kilkens T.O., Lindsey P.J., Hamer H.M., Jonkers D.M., et al. The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroenterology and Motility 2009, 21:952-e976.
176. Velazquez O.C., Lederer H.M., Rombeau J.L. Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications. Advances in Experimental Medicine and Biology 1997, 427:123-134.
177. Venema K. Role of gut microbiota in the control of energy and carbohydrate metabolism. Current Opinion in Clinical Nutrition and Metabolic Care 2010, 13:432-438.
178. Venema K., de Graaf A.A., Maathuis A.J.H., Kovatcheva-Datchary P., Smidt H. Fermentation in the large intestine unraveled using 13C-labeled substrates! - Implications for obesity and gut health. Dietary fibre: New frontiers for food and health 2010, 539-553. Wageningen Academic Publishers, Wageningen, The Netherlands. J.W. van der Kamp, J. Jones, B. McCleary, D. Topping (Eds.).
179. Venema K., Havenaar R., Minekus M. Improving in vitro simulation of the GI-tract - models that mimic the stomach and intestines. Designing functional foods - measuring and controlling food structure breakdown and nutrient absorption 2009, 314-339. Woodhead Publishing Ltd, Cambridge, UK. J.D. McClements, E.A. Decker (Eds.).
180. Venema K., van Nuenen H.M.C., van den Heuvel E.G., Pool W., van der Vossen J.M.B.M. The effect of lactulose on the composition of the intestinal microbiota and short-chain fatty acid production in human volunteers and a computer-controlled model of the proximal large intestine. Microbial Ecology in Health and Disease 2003, 15:94-105.
181. Vesa T.H., Marteau P., Korpela R. Lactose intolerance. Journal of the American College of Nutrition 2000, 19:165S-175S.
182. Vonk R.J., Priebe M.G., Koetse H.A., Stellaard F., Lenoir-Wijnkoop I., Antoine J.M., et al. Lactose intolerance: analysis of underlying factors. European Journal of Clinical Investigation 2003, 33:70-75.
183. de Vrese M., Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Advances in Biochemical Engineering/Biotechnology 2008, 111:1-66.
184. de Vrese M., Stegelmann A., Richter B., Fenselau S., Laue C., Schrezenmeir J. Probiotics - compensation for lactase insufficiency. American Journal of Clinical Nutrition 2001, 73:421S-429S.
185. Vulevic J., Drakoularakou A., Yaqoob P., Tzortzis G., Gibson G.R. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. American Journal of Clinical Nutrition 2008, 88:1438-1446.
186. Wada J., Ando T., Kiyohara M., Ashida H., Kitaoka M., Yamaguchi M., et al. Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Applied and Environmental Microbiology 2008, 74:3996-4004.
187. Ward R.E., Ninonuevo M., Mills D.A., Lebrilla C.B., German J.B. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Applied and Environmental Microbiology 2006, 72:4497-4499.
188. Ward R.E., Ninonuevo M., Mills D.A., Lebrilla C.B., German J.B. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Molecular Nutrition and Food Research 2007, 51:1398-1405.
189. Wilson K.H., Blitchington R.B. Human colonic biota studied by ribosomal DNA sequence analysis. Applied and Environmental Microbiology 1996, 62:2273-2278.
190. Wu S., Tao N., German J.B., Grimm R., Lebrilla C.B. Development of an annotated library of neutral human milk oligosaccharides. Journal of Proteome Research 2010, 9:4138-4151.
191. Xiao J.Z., Takahashi S., Nishimoto M., Odamaki T., Yaeshima T., Iwatsuki K., et al. Distribution of in vitro fermentation ability of lacto-N-biose I, a major building block of human milk oligosaccharides, in bifidobacterial strains. Applied and Environmental Microbiology 2010, 76:54-59.
192. Zhong Y., Priebe M.G., Vonk R.J., Huang C.Y., Antoine J.M., He T., et al. The role of colonic microbiota in lactose intolerance. Digestive Diseases and Sciences 2004, 49:78-83.
193. Zivkovic A.M., German J.B., Lebrilla C.B., Mills D.A. Microbes and health Sackler colloquium: human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proceedings of the National Academy of Sciences of the United States of America 2010, 108(Suppl. 1):4653-4658.
194. Zoetendal E.G., Akkermans A.D., De Vos W.M. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Applied and Environmental Microbiology 1998, 64:3854-3859.
195. Zoetendal E.G., Cheng B., Koike S., Mackie R.I. Molecular microbial ecology of the gastrointestinal tract: from phylogeny to function. Current Issues in Intestinal Microbiology 2004, 5:31-47.
196. Zoetendal E.G., Collier C.T., Koike S., Mackie R.I., Gaskins H.R. Molecular ecological analysis of the gastrointestinal microbiota: a review. Journal of Nutrition 2004, 134:465-472.
197. Zoetendal E.G., Vaughan E.E., de Vos W.M. A microbial world within us. Molecular Microbiology 2006, 59:1639-1650.